RenovoRx Inc’s recent filing unveils that its Chief Medical Officer Agah Ramtin acquired Company’s shares for reported $29400.0 on Jun 05 ’25. In the deal valued at $1.40 per share,21,000 shares were bought. As a result of this transaction, Agah Ramtin now holds 734,460 shares worth roughly $0.97 million.
Then, Agah Ramtin bought 15,000 shares, generating $13,500 in total proceeds. Upon buying the shares at $0.90, the Chief Medical Officer now owns 1,113,460 shares.
Before that, Bagai Shaun bought 7,500 shares. RenovoRx Inc shares valued at $6,821 were divested by the Chief Executive Officer at a price of $0.91 per share. As a result of the transaction, Bagai Shaun now holds 320,040 shares, worth roughly $0.42 million.
Price Performance Review of RNXT
On Tuesday, RenovoRx Inc [NASDAQ:RNXT] saw its stock fall -5.71% to $1.32. Over the last five days, the stock has gained 1.54%. RenovoRx Inc shares have risen nearly 12.82% since the year began. Nevertheless, the stocks have risen 2.33% over the past one year. While a 52-week high of $1.69 was reached on 01/21/25, a 52-week low of $0.75 was recorded on 04/07/25.
Levels Of Support And Resistance For RNXT Stock
The 24-hour chart illustrates a support level at 1.2833, which if violated will result in even more drops to 1.2467. On the upside, there is a resistance level at 1.3733. A further resistance level may holdings at 1.4267.
How much short interest is there in RenovoRx Inc?
A steep rise in short interest was recorded in RenovoRx Inc stocks on 2025-06-13, dropping by -0.12 million shares to a total of 0.14 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.26 million shares. There was a decline of -88.66%, which implies that there is a negative sentiment for the stock.
